@MrFamilyOffice Strategy runs $80m. .02 correlation to s&p. 1.79 monthly sharpe, 2.04 monthly sortino. 10% annualized vol with 21.6% avg annual return. High liquidity. Looking to scale this to $1B. Dm for more discussion/details. Thanks @MrFamilyOffice
@ZeeContrarian1 After my own research I’m not seeing how they have more cash than their market cap at $24 a share. Can you explain how you came to that conclusion?
@cryptopunk7213@awilkinson It’s a downward housing market. If it sold in 5 days, he priced it too low. He’s probably kicking himself when he thinks about it.
$KMDA is a boring, under-the-radar plasma biotech that operates in an effective oligopoly in the rabies immunoglobulin market. Real products, steady demand, predictable cash flows trading at valuations that don’t reflect that stability.